CIDRAP newsletters options
The agency will not act as a stand-alone regulatory body, but as a coordinator.
Also, FDA documents show the Pfizer vaccine is 91% effective in younger kids.
Cognitive impairment patterns occurred in relatively young patients and echoed findings seen in those who recovered from other viral illnesses.
Preliminary data from a phase 3 trial in three countries was released this week at an international conference.
Rises in the UK have been a bellwether for emerging patterns in the United States.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Oct 21
The Centers for Disease Control and Prevention (CDC) said today that lab tests have identified a rare, potentially deadly bacterium in an aromatherapy spray.
Two recent studies in Pediatrics look at risk factors for severe pediatric COVID-19 and COVID deaths in those younger than 21 years of age.
One study shows a 30% lower vaccination rate, and another higher rates of severe disease and death.
An estimated 80,000 to 180,000 healthcare workers died from COVID-19 in the pandemic's first 17 months.
Many people who received Moderna and all who got J&J vaccines should receive a booster, advisers say.
Experts say antibiotic resistance is a "complex web of related problems" that will require a One Health response.
A review of antibiotic prescribing at Veterans' Health Administration (VHA) mental health units found that only 1 in 10 patients were exposed to antibiotics, but urinary tract infections (UTIs) appeared to be frequently misdiagnosed, researchers reported today in Infection Control & Hospital Epidemiology.
COVID-19 vaccination does not increase the risk of miscarriage during the first trimester of pregnancy, according to a Norwegian case-control study that involved 13,956 women, 5.5% of whom were vaccinated against the virus. The results were published yesterday as a letter to the editor in the New England Journal of Medicine.
For the third week in a row, illness numbers in Europe rose, with a 7% jump last week.
Two large studies show very high protection against the more transmissible variant.
Officials are preparing to vaccinate up to 28 million US children aged 5 to 11 as soon as approval is granted.
Studies look at COVID-19 immune responses in pregnant women.
COVID-19 outpatients were more likely to have more respiratory symptoms if they were overweight or obese, according to a study published yesterday in Influenza and Other Respiratory Viruses.
France-based Valneva reports positive results for its vaccine compared with the AstraZeneca vaccine.